Drug interactions between olaparib and pembrolizumab
Interactions between your drugs
There were no interactions found in our database between olaparib and pembrolizumab - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Olaparib is in the drug class PARP inhibitors.
- Olaparib is used to treat the following conditions:
- Pembrolizumab is a member of the drug class Anti-PD-1 monoclonal antibodies.
- Pembrolizumab is used to treat the following conditions:
Drug and food interactions
Applies to: olaparib
Do not consume grapefruit, grapefruit juice, or Seville oranges during treatment with olaparib. Doing so can significantly increase the blood levels of olaparib and increase the risk and/or severity of side effects such as nausea, vomiting, diarrhea, indigestion, loss of appetite, abdominal pain or discomfort, lung problems, and impaired bone marrow function resulting in low numbers of different types of blood cells. You may also be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No therapeutic duplications were found for your selected drugs.
Drug Interaction Classification
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.